Fecal Immunochemical Test (FIT) Screening Guidelines
Screening Frequency
- The American College of Physicians, American Cancer Society, and U.S. Preventive Services Task Force recommend annual FIT testing for average-risk adults, with strong recommendation and moderate-quality evidence supporting its use 1, 2, 3, 4
- The U.S. Multi-Society Task Force also recommends annual FIT testing, with moderate-quality evidence supporting its use 1, 2, 3, 4
- The Canadian Task Force on Preventive Health Care recommends FIT every 2 years for adults aged 50-74 years, though this represents an outlier position compared to the predominant global recommendation of annual testing 1, 5
Age to Begin Screening
- The American Cancer Society recommends starting FIT screening at age 45 years for all average-risk adults, though this carries a qualified recommendation with moderate certainty 3
- The U.S. Preventive Services Task Force recommends screening from age 50-75 years, with the strongest recommendation and most robust evidence for mortality benefit 1, 2, 3, 4
- African Americans may benefit from beginning screening at age 45 years based on higher CRC incidence and mortality rates in this population, though this is a weak recommendation with very-low-quality evidence 2, 4
Age to Stop Screening
- The American College of Physicians recommends continuing annual FIT through age 75 years in adults with good health and life expectancy greater than 10 years 1, 2, 3, 4
- The U.S. Preventive Services Task Force recommends individualizing screening decisions for ages 76-85 years based on prior screening history, overall health status, and life expectancy exceeding 10 years 1, 2, 3, 4, 6
- The American Cancer Society recommends discontinuing screening after age 85 years as harms outweigh benefits regardless of prior screening history 3, 6
- Screening should be stopped when life expectancy is less than 10 years due to comorbidities, as screening is unlikely to provide benefit 2, 4, 6
Critical Implementation Requirements
- The U.S. Preventive Services Task Force emphasizes that annual testing commitment is essential, and one-time or sporadic FIT testing has very limited sensitivity and makes stool testing a poor screening choice 4
- Patients must understand that all positive FIT results require immediate follow-up colonoscopy to rule out colorectal cancer or advanced neoplasia 4